@vpuntmann.bsky.social

Myoflame-19 is a multicentre randomised placebo-controlled clinical trial of 16-week therapy targeting endothelial dysfunction due to persistent low-grade inflammation in patients with Long COVID. The recruitment is ongoing and will conclude by the end of 03/25 (Registration via www.myoflame.com)

Home

myoflame.com